Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04692337 · ClinicalTrials.gov registry record · NA

Ommaya Reservoir Placement for Brain Tumor Biomarker Access

A NA study of Brain Tumor, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04692337 is a NA study of Brain Tumor that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04692337, a NA study of Brain Tumor, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the safety and feasibility of intra-operative Ommaya Reservoir placement during a clinically indicated operation for brain tumor. The Ommaya reservoir will facilitate a longitudinal access to cerebrospinal fluid (CSF) for analysis of potential biomarkers for brain tumor research and individualized monitoring.

Conditions Studied

Interventions

  • PROCEDURE Intra-operative Ommaya Reservoir placement

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-01-15
Est. Completion 2027-02-28
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04692337

The ClinicalTrials.gov registry entry for NCT04692337 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (64% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Intra-operative Ommaya Reservoir placement is the first listed.

NCT04692337 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04692337 about?

NCT04692337 is a clinical study titled "Ommaya Reservoir Placement for Brain Tumor Biomarker Access". The purpose of this study is to determine the safety and feasibility of intra-operative Ommaya Reservoir placement during a clinically indicated operation for brain tumor. The Ommaya reservoir will facilitate a longitudinal access to cerebrospinal fluid (CSF) for analysis of potential biomarkers for...

What is the current status of trial NCT04692337?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-01-15. Estimated completion is 2027-02-28.

What conditions does trial NCT04692337 study?

This clinical trial studies the following conditions: Brain Tumor.

What interventions are being tested in trial NCT04692337?

The interventions under investigation include: Intra-operative Ommaya Reservoir placement (PROCEDURE).

Who is sponsoring clinical trial NCT04692337?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04692337 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.